MRK vs V: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
VS
Visa Inc. · Financial Services
$368.29
+25.7% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
V has more upside to fair value
(+25.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
V |
| Current Price |
$147.17 |
$368.29 |
| Fair Value Estimate |
$141.07 |
$463.00 |
| Upside to Fair Value |
-4.1%
|
+25.7%
|
| Market Cap |
$363.5B |
$687.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
24.0x
|
| Price / Sales |
5.5x
|
15.5x
|
| Price / FCF |
22.6x
|
33.5x
|
| Revenue Growth YoY |
+5.1%
|
+14.4%
|
| Gross Margin |
75.4%
|
80.2%
|
| Operating Margin |
16.7%
|
60.7%
|
| Return on Equity |
6.6%
|
61.3%
|
| Dividend Yield |
2.31% |
0.73% |
| FCF Yield |
4.42%
|
2.98%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Visa operates the world's largest retail payments network, connecting consumers, merchants, issuers, and acquirers through VisaNet, which authorizes, clears, and settles transactions across more than 200 countries. The business quality is exceptional: TTM gross margin of 80.2%, operating margin of 60.7%, net margin of 50.8%, and ROE of 61.3% reflect a two-sided network with powerful scale economi…
Accumulation Zones
| Metric |
MRK |
V |
| Zone Low |
$105.80 |
$347.25 |
| Zone High |
$119.91 |
$393.55 |
| In Buy Zone? |
No
|
Yes
|